Fujifilm Joins In Study Of iPS Cell Treatment For Inherited Alzheimer's
This article was originally published in PharmAsia News
Executive Summary
Alzheimer's disease patients vary wildly in their pathological features, leading Fujifilm and the Kyoto University Center for iPS Cell Research to join in developing a single drug effective for all of them.